Panitumumab: A Review of Clinical Pharmacokinetic and Pharmacology Properties After Over a Decade of Experience in Patients with Solid Tumors
Crossref DOI link: https://doi.org/10.1007/s12325-021-01809-4
Published Online: 2021-06-18
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kast, Johannes
Dutta, Sandeep
Upreti, Vijay V. http://orcid.org/0000-0003-1018-7166
Funding for this research was provided by:
Amgen
Text and Data Mining valid from 2021-06-18
Version of Record valid from 2021-06-18
Article History
Received: 23 March 2021
Accepted: 26 May 2021
First Online: 18 June 2021